A comprehensive nomogram for assessing the prognosis of non-small cell lung cancer patients receiving immunotherapy: a prospective cohort study in China
A prognostic model for OS in NSCLC patients receiving immunotherapy was established, providing a simple and reliable tool for predicting patient survival (https://icisnsclc.shinyapps.io/DynNomapp/). This model offers valuable guidance for clinicians in making treatment decisions and recommendations.
Authors
- Wei Zhang (ORCID: https://orcid.org/0000-0002-5111-4097)
- Haike Lei (ORCID: https://orcid.org/0000-0003-0284-2052)
- Qianjie Xu (ORCID: https://orcid.org/0000-0002-3195-8372)
- Xiaosheng Li (ORCID: https://orcid.org/0009-0007-4507-2488)
- Yuliang Yuan (ORCID: https://orcid.org/0000-0003-3817-2687)
- Zuhai Hu
- Gang Liang (ORCID: https://orcid.org/0000-0002-7153-8014)
- Hongmei Li (ORCID: https://orcid.org/0009-0000-3569-1049)
Institutions
- Chongqing University (CN)
- Chongqing Public Health Medical Center (CN)
- Chongqing Cancer Hospital (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-20
- DOI
- https://doi.org/10.3389/fimmu.2024.1487078
- Citations
- 5
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.41
Funders
- Natural Science Foundation of Chongqing
- Centre Scientifique et Technique du Bâtiment